AJP - Lung Fuel your research with LabChart
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Lung Cell Mol Physiol 290: L162-L169, 2006; doi:10.1152/ajplung.00252.2005
1040-0605/06 $8.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (10)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Miller, M.
Right arrow Articles by Broide, D. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Miller, M.
Right arrow Articles by Broide, D. H.

Corticosteroids prevent myofibroblast accumulation and airway remodeling in mice

Marina Miller, Jae Youn Cho, Kirsti McElwain, Shauna McElwain, Jung Yeon Shim, Michael Manni, Ji Sun Baek, and David H. Broide

Department of Medicine, University of California San Diego, San Diego, California

Submitted 9 June 2005 ; accepted in final form 12 August 2005

At present there are conflicting results from studies investigating the role of corticosteroids in inhibiting airway remodeling in asthma. We have used a mouse model to determine whether administration of corticosteroids prevents the development of allergen-induced structural features of airway remodeling. Mice treated with corticosteroids were subjected to repetitive ovalbumin (OVA) challenge for 3 mo, at which time levels of peribronchial fibrosis and the thickness of the peribronchial smooth muscle layer were assessed by immunohistology, levels of transforming growth factor (TGF)-{beta}1 by ELISA, and the number of {alpha}-smooth muscle actin+/Col-1+ peribronchial myofibroblasts by immunohistochemistry. Corticosteroids significantly reduced allergen-induced increases in peribronchial collagen deposition and levels of total lung collagen but did not reduce allergen-induced increases in the thickness of the peribronchial smooth muscle layer. Levels of lung TGF-{beta}1 were significantly reduced in mice treated with systemic corticosteroids, and this was associated with a significant decrease in the number of peribronchial inflammatory cells that expressed TGF-{beta}1, including eosinophils and mononuclear cells. Corticosteroids also significantly reduced the number of peribronchial myofibroblasts. Overall, these studies demonstrate that administration of corticosteroids significantly reduces levels of allergen-induced peribronchial fibrosis. The reduction in peribronchial fibrosis mediated by corticosteroids is likely to be due to several mechanisms including inhibition of expression of TGF-{beta}1, a reduction in the number of peribronchial inflammatory cells expressing TGF-{beta}1 (eosinophils, macrophages), as well as by corticosteroids reducing the accumulation of peribronchial myofibroblasts that contribute to collagen expression.

eosinophil; allergy; transforming growth factor-{beta}1



Address for reprint requests and other correspondence: D. Broide, Univ. of California San Diego, Basic Science Bldg., Rm. 5090, 9500 Gilman Dr., La Jolla, CA 92093-0635 (e-mail: dbroide{at}ucsd.edu)




This article has been cited by other articles:


Home page
Am. J. Respir. Cell Mol. Bio.Home page
C. K. Andersson, H.-E. Claesson, K. Rydell-Tormanen, S. Swedmark, A. Hallgren, and J. S. Erjefalt
Mice Lacking 12/15-Lipoxygenase Have Attenuated Airway Allergic Inflammation and Remodeling
Am. J. Respir. Cell Mol. Biol., December 1, 2008; 39(6): 648 - 656.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
J. R. Johnson, S. R. Pacitto, J. Wong, E. W. Archer, S. Eirefelt, A. Miller-Larsson, and M. Jordana
Combined budesonide/formoterol therapy in conjunction with allergen avoidance ameliorates house dust mite-induced airway remodeling and dysfunction
Am J Physiol Lung Cell Mol Physiol, November 1, 2008; 295(5): L780 - L788.
[Abstract] [Full Text] [PDF]


Home page
Eur Respir JHome page
D. S. Southam, R. Ellis, J. Wattie, S. Young, and M. D. Inman
Budesonide prevents but does not reverse sustained airway hyperresponsiveness in mice
Eur. Respir. J., October 1, 2008; 32(4): 970 - 978.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
A. M. Misior, H. Yan, R. M. Pascual, D. A. Deshpande, R. A. Panettieri, and R. B. Penn
Mitogenic Effects of Cytokines on Smooth Muscle Are Critically Dependent on Protein Kinase A and Are Unmasked by Steroids and Cyclooxygenase Inhibitors
Mol. Pharmacol., February 1, 2008; 73(2): 566 - 574.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
O. Tliba, Y. Amrani, and R. A. Panettieri Jr
Is Airway Smooth Muscle the "Missing Link" Modulating Airway Inflammation in Asthma?
Chest, January 1, 2008; 133(1): 236 - 242.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
G. Cheng, Z. Shao, B. Chaudhari, and D. K. Agrawal
Involvement of chloride channels in TGF-beta1-induced apoptosis of human bronchial epithelial cells
Am J Physiol Lung Cell Mol Physiol, November 1, 2007; 293(5): L1339 - L1347.
[Abstract] [Full Text] [PDF]


Home page
Eur Respir JHome page
E. D. Fixman, A. Stewart, and J. G. Martin
Basic mechanisms of development of airway structural changes in asthma
Eur. Respir. J., February 1, 2007; 29(2): 379 - 389.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 2006 by the American Physiological Society.